Carmustine Implants in Treating Patients With Brain Metastases

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2002

Study Completion Date

April 30, 2003

Conditions
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

polifeprosan 20 with carmustine implant

PROCEDURE

conventional surgery

Trial Locations (11)

30322

Emory University Hospital - Atlanta, Atlanta

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

48202

Henry Ford Hospital, Detroit

35294-3295

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02114-2617

Massachusetts General Hospital Cancer Center, Boston

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

27157-1030

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

19104-4283

University of Pennsylvania Cancer Center, Philadelphia

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

New Approaches to Brain Tumor Therapy Consortium

OTHER

NCT00003878 - Carmustine Implants in Treating Patients With Brain Metastases | Biotech Hunter | Biotech Hunter